@article{11b2e9a8aef54be9936013fc2f40685d,
title = "Chimeric antigen receptor T-cell therapy for haematological malignancies",
keywords = "Artificial intelligence, Hematologic neoplasms",
author = "Selim, \{Adrian G.\} and Tam, \{Constantine S.\}",
note = "Funding Information: Adrian Selim has received honoraria from Novartis. Constantine Tam was a principal investigator on the JULIET study sponsored by Novartis, and receives research funding from Janssen and AbbVie, and honoraria from Janssen, AbbVie, BeiGene, Novartis and Roche. ",
year = "2020",
month = nov,
day = "2",
doi = "10.5694/mja2.50783",
language = "English",
volume = "213",
pages = "404--406.e1",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "Wiley-Blackwell",
number = "9",
}